Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q2 2025 · 10-Q
Revenue$107.42M$107.42M+18.9% vs Q2 2024 Net Income-$321.69M-$321.69MN/M vs Q2 2024 EPS Diluted-$1.70-$1.70N/M vs Q2 2024 Operating Income-$312,876,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$209,053,000N/M Margins · derivedOperating margin-291.3%+28.5 pt vs Q2 2024
Net margin-299.5%+33.3 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 7, 2025 · 38 d after period end